Capsule Summaries

Share

Program Content

Activities

  • PURPOSE 1: Persistence
    PURPOSE 1: PrEP Adherence and Persistence With Twice Yearly LEN Injections vs Daily Oral PrEP
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 20, 2024

    Expires: November 19, 2025

  • LA CAB/RPV + LEN for HIV Treatment
    LA CAB/RPV + LEN in People With HIV, Adherence Challenges, and INSTI/NNRTI Resistance Mutations
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 24, 2024

    Expires: October 23, 2025

  • OPERA: LA CAB PrEP
    OPERA: Real-world Experience With LA CAB PrEP
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 24, 2024

    Expires: October 23, 2025

  • TRIO: Real-World LA CAB for PrEP
    TRIO COHORT: Real-World LA CAB for PrEP Over the First 2 Years
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 25, 2024

    Expires: October 24, 2025

  • CAPELLA: LEN Wk 156 Results
    CAPELLA: Wk 156 Results With LA SC Lenacapavir in Persons Living With Multidrug-Resistant HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 30, 2024

    Expires: October 29, 2025

  • Phase II ISL + LEN: Wk 48
    Once-Weekly Oral ISL + LEN in Virologically Suppressed People Living With HIV: Wk 48 Results
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 14, 2024

    Expires: November 13, 2025

  • LA CAB PrEP in Pharmacies
    LA CAB PrEP in Community Pharmacy Setting: Wk 26 Acceptability and Feasibility Data
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 14, 2024

    Expires: November 13, 2025

  • DOLCE: DTG/3TC and Low CD4 Count
    DOLCE: DTG/3TC in Treatment-Naive People Living With HIV and Low CD4+ Cell Counts
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2024

    Expires: November 14, 2025

  • ROSETTA-registry
    ROSETTA-registry: Identification of Resistance Patterns to Second-Generation INSTIs
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 20, 2024

    Expires: November 19, 2025

  • PRIDOX: DoxyPEP
    PRIDOX: DoxyPEP for Men Who Have Sex With Men at High Risk for Sexually Transmitted Infections
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2024

    Expires: November 21, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare